Fund invests 35 MSEK in Diamyd

Diamyd Medical has accepted an offer from an investment fund managed from New York by a Swedish-American team to issue 291,667 new B shares in a direct placement at 120 SEK per share. The issue price corresponds to the average market price of the past 30 trading days. Total proceeds for Diamyd amounts to 35 MSEK.“We welcome an additional investor with a long term horizon to our list of major shareholders,” says Elisabeth Lindner, CEO and President of Diamyd Medical. “This new capital allows us to create shareholder value in areas outside our Phase III program, in line with our objective to